The DOI matches its Crossref record; 487 of the 487 references it cites were found in a registry or an index.
Changes in Proinflammatory Cytokine Activity after Menopause
Abstract
There is now a large body of evidence suggesting that the decline in ovarian function with menopause is associated with spontaneous increases in proinflammatory cytokines. The cytokines that have obtained the most attention are IL-1, IL-6, and TNF-α. The exact mechanisms by which estrogen interferes with cytokine activity are still incompletely known but may potentially include interactions of the ER with other transcription factors, modulation of nitric oxide activity, antioxidative effects, plasma membrane actions, and changes in immune cell function. Experimental and clinical studies strongly support a link between the increased state of proinflammatory cytokine activity and postmenopausal bone loss. Preliminary evidence suggests that these changes also might be relevant to vascular homeostasis and the development of atherosclerosis. Better knowledge of the mechanisms and the time course of these interactions may open new avenues for the prevention and treatment of some of the most prevalent and important disorders in postmenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520
RetractedAtherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“The findings that circulating IL-6 levels predict femoral bone loss in early postmenopausal women (399) and that IL-6-derived C-reactive protein strongly predicts the development of symptomatic coronary artery disease (407) make these measurements attractive parameters for the identification of high-risk groups of ear…”
BackgroundOsteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 1×
“RANKL- and RANK-deficient mice have a complete block in osteoclast development and show significant alterations in both immune cells and immune cell organs with a lack of lymph node development (227, 228).”
BackgroundThe Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,103
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Rajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,449
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
Conditions controlling the proliferation of haemopoietic stem cells in vitro
Dexter, T. M., Allen, T. D., & Lajtha, L. G. (1977) · Journal of Cellular Physiology · doi:10.1002/jcp.1040910303 · Cited by 2,066
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 1,997
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Ridker, P. M. (2001) · Circulation · doi:10.1161/01.cir.103.13.1813 · Cited by 1,402
The c-fos protein interacts with c-JunAP-1 to stimulate transcription of AP-1 responsive genes
Chiu, R., Boyle, W. J., Meek, J., Smeal, T., Hunter, T., & Karin, M. (1988) · Cell · doi:10.1016/0092-8674(88)90076-1 · Cited by 1,335
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,304
Increased adipose tissue in male and female estrogen receptor-α knockout mice
Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12729 · Cited by 1,282
Daynes, R. A., Araneo, B. A., Ershler, W. B., Maloney, C., Li, G. Z., & Ryu, S. Y. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5219 · Cited by 1,264
Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials
LaRosa, J. C., He, J., & Vupputuri, S. (1999) · JAMA · doi:10.1001/jama.282.24.2340 · Cited by 1,246
Evidence of Estrogen Receptors in Normal Human Osteoblast-Like Cells
Eriksen, E. F., Colvard, D. S., Berg, N. J., Graham, M. L., Mann, K. G., Spelsberg, T. C., & Riggs, B. L. (1988) · Science · doi:10.1126/science.3388021 · Cited by 1,229
Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,173
The aging immune system: primer and prospectus
Miller, R. A. (1996) · Science · doi:10.1126/science.273.5271.70 · Cited by 1,165 · cited 1×
“On the contrary, it is also possible that age-related changes in cellular function, and particularly in immune cell function, may compensate for the intracellular pathways that are activated by estrogen deficiency, including estrogen-independent activation of the ER itself (450).”
BackgroundThe Pathogenesis of Atherosclerosis: (Second of Two Parts)
Ross, R., & Glomset, J. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608192950805 · Cited by 1,163
Fried, S. K. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.847 · Cited by 1,145
Riggs, B. L., Khosla, S., & Melton, L. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.763 · Cited by 1,143
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
IL-6 is produced by osteoblasts and induces bone resorption.
Ishimi, Y., Miyaura, C., Jin, C. H., Akatsu, T., Abe, E., Nakamura, Y., Yamaguchi, A., Yoshiki, S., Matsuda, T., Hirano, T., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3297 · Cited by 1,128
Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119
Bastard, J.-P. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3338 · Cited by 1,104
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
Denhardt, D. T., Noda, M., O’Regan, A. W., Pavlin, D., & Berman, J. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12980 · Cited by 1,059
An interleukin 1 like factor stimulates bone resorption in vitro
Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., & Russell, R. G. G. (1983) · Nature · doi:10.1038/306378a0 · Cited by 1,012
Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/01.cir.103.16.2055 · Cited by 1,012
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 970
Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10193 · Cited by 959
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., & Olefsky, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 926
Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., & Shaul, P. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5347 · Cited by 923
Reactive Oxygen-Mediated Protein Oxidation in Aging and Disease
Stadtman, E. R., & Berlett, B. S. (1998) · Drug Metabolism Reviews · doi:10.3109/03602539808996310 · Cited by 891
Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., & Boyce, B. F. (1996) · Nature Medicine · doi:10.1038/nm1096-1132 · Cited by 813
Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-Like Osteosarcoma Cells
Komm, B. S., Terpening, C. M., Benz, D. J., Graeme, K. A., Gallegos, A., Korc, M., Greene, G. L., O'Malley, B. W., & Haussler, M. R. (1988) · Science · doi:10.1126/science.3164526 · Cited by 812
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
Schmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
Philip, R., & Epstein, L. B. (1986) · Nature · doi:10.1038/323086a0 · Cited by 767
Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by Osteoclasts
Azuma, Y., Kaji, K., Katogi, R., Takeshita, S., & Kudo, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4858 · Cited by 731
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
Jones, M. E. E., Thorburn, A. W., Britt, K. L., Hewitt, K. N., Wreford, N. G., Proietto, J., Oz, O. K., Leury, B. J., Robertson, K. M., Yao, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12735 · Cited by 729
Gonadal Steroids and Immunity*
OLSEN, N. J., & KOVACS, W. J. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-369 · Cited by 715
Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB
Peng, H.-B., Libby, P., & Liao, J. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.14214 · Cited by 710
Garnero, P., Sornay-Rendu, E., Claustrat, B., & Delmas, P. D. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.8.1526 · Cited by 709
Chrousos, G. P., Torpy, D. J., & Gold, P. W. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-3-199808010-00012 · Cited by 706
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α
Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11066 · Cited by 705
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 704
The crippling consequences of fractures and their impact on quality of life
Cooper, C. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)90022-x · Cited by 699
Webb, P. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.443 · Cited by 693
Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Spelsberg, T. C., & Riggs, B. L. (1999) · Endocrinology · doi:10.1210/endo.140.9.7131 · Cited by 692 · cited 1×
“Estrogen dose dependently increased levels of OPG mRNA and protein in human osteoblastic cells (231) and stromal cells (232).”
BackgroundThe ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.
Burgess, T. L., Qian, Y.-X., Kaufman, S., Ring, B. D., Van, G., Capparelli, C., Kelley, M., Hsu, H., Boyle, W. J., Dunstan, C. R., et al. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.3.527 · Cited by 689
Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., & Manolagas, S. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115668 · Cited by 679
Increased cytokine production in mononuclear cells of healthy elderly people
Fagiolo, U., Cossarizza, A., Scala, E., Fanales‐Belasio, E., Ortolani, C., Cozzi, E., Monti, D., Franceschi, C., & Paganelli, R. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230950 · Cited by 665 · cited 1×
“Inflammatory conditions tend to increase age independently from menopause (448, 449), and it is thus possible that ageassociated increases in proinflammatory cytokines may simply dilute the impact of menopause on cytokine metabolism.”
BackgroundInterleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA
Raines, E. W., Dower, S. K., & Ross, R. (1989) · Science · doi:10.1126/science.2783498 · Cited by 646
Rapid actions of plasma membrane estrogen receptors
Kelly, M. J., & Levin, E. R. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00377-0 · Cited by 643
The vascular protective effects of estrogen
Farhat, M. Y., Lavigne, M. C., & Ramwell, P. W. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621060 · Cited by 639
Hofbauer, L. C., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., Riggs, B. L., & Khosla, S. (1999) · Bone · doi:10.1016/s8756-3282(99)00162-3 · Cited by 631
Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency
Bilezikian, J. P., Morishima, A., Bell, J., & Grumbach, M. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390905 · Cited by 625
Hot Flashes: Epidemiology and Physiology a
KRONENBERG, F. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb30316.x · Cited by 601
Baulieu, E.-E., Thomas, G., Legrain, S., Lahlou, N., Roger, M., Debuire, B., Faucounau, V., Girard, L., Hervy, M.-P., Latour, F., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4279 · Cited by 577
Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E. R., Kurokawa, T., & Suda, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116179 · Cited by 577
Haynes, M. P., Sinha, D., Russell, K. S., Collinge, M., Fulton, D., Morales-Ruiz, M., Sessa, W. C., & Bender, J. R. (2000) · Circulation Research · doi:10.1161/01.res.87.8.677 · Cited by 575
Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels
Ashcroft, G. S., Dodsworth, J., Boxtel, E. V., Tarnuzzer, R. W., Horan, M. A., Schultz, G. S., & Ferguson, M. W. J. (1997) · Nature Medicine · doi:10.1038/nm1197-1209 · Cited by 573
Inducible Nitric Oxide Synthase and Inflammatory Diseases
Zamora, R., Vodovotz, Y., & Billiar, T. R. (2000) · Molecular Medicine · doi:10.1007/bf03401781 · Cited by 558
Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-α*
Gilbert, L., He, X., Farmer, P., Boden, S., Kozlowski, M., Rubin, J., & Nanes, M. S. (2000) · Endocrinology · doi:10.1210/endo.141.11.7739 · Cited by 555
Pacifici, R., Brown, C., Puscheck, E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., & Avioli, L. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5134 · Cited by 555
Min, H., Morony, S., Sarosi, I., Dunstan, C. R., Capparelli, C., Scully, S., Van, G., Kaufman, S., Kostenuik, P. J., Lacey, D. L., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.463 · Cited by 550
Thomson, B. M., Mundy, G. R., & Chambers, T. J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.775 · Cited by 536
IL-1 stimulates IL-6 production in endothelial cells.
Sironi, M., Breviario, F., Proserpio, P., Biondi, A., Vecchi, A., Van Damme, J., Dejana, E., & Mantovani, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.549 · Cited by 521
Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-resorbing Osteoclasts
Kameda, T., Mano, H., Yuasa, T., Mori, Y., Miyazawa, K., Shiokawa, M., Nakamaru, Y., Hiroi, E., Hiura, K., Kameda, A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.4.489 · Cited by 519
Nakashima, T., Kobayashi, Y., Yamasaki, S., Kawakami, A., Eguchi, K., Sasaki, H., & Sakai, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3379 · Cited by 509
Browner, W. S., Lui, L.-Y., & Cummings, S. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7192 · Cited by 506
Shevde, N. K., Bendixen, A. C., Dienger, K. M., & Pike, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130200197 · Cited by 502
Transforming Growth Factor-β Gene Family Members and Bone*
CENTRELLA, M., HOROWITZ, M. C., WOZNEY, J. M., & MCCARTHY, T. L. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-1-27 · Cited by 487
Kurihara, N., Bertolini, D., Suda, T., Akiyama, Y., & Roodman, G. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.11.4226 · Cited by 486
The effect of a single dose of osteoprotegerin in postmenopausal women.
Bekker, P. J., Holloway, D., Nakanishi, A., Arrighi, M., Leese, P. T., & Dunstan, C. R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.348 · Cited by 484
Gowen, M., & Mundy, G. R. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2478 · Cited by 476
Role and regulation of cyclooxygenase-2 during inflammation
Simon, L. S. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00115-1 · Cited by 474
Pfeilschifter, J., Chenu, C., Bird, A., Mundy, G. R., & Roodman, D. G. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040116 · Cited by 468
Self-citationActivation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex
Gaub, M.-P., Bellard, M., Scheuer, I., Chambon, P., & Sassone-Corsi, P. (1990) · Cell · doi:10.1016/0092-8674(90)90422-b · Cited by 468
Takahashi, N., Udagawa, N., & Suda, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0252 · Cited by 463
Zeiher, A. M., Fisslthaler, B., Schray-Utz, B., & Busse, R. (1995) · Circulation Research · doi:10.1161/01.res.76.6.980 · Cited by 462
Cytokines and Estrogen in Bone: Anti-Osteoporotic Effects
Horowitz, M. C. (1993) · Science · doi:10.1126/science.8480174 · Cited by 453
The mechanisms of estrogen regulation of bone resorption
Riggs, B. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11468 · Cited by 446
Interleukin-6 Exacerbates Early Atherosclerosis in Mice
Huber, S. A., Sakkinen, P., Conze, D., Hardin, N., & Tracy, R. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2364 · Cited by 443
Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
Haarbo, J., Marslew, U., Gotfredsen, A., & Christiansen, C. (1991) · Metabolism · doi:10.1016/0026-0495(91)90037-w · Cited by 441
Burger, H. G., Dudley, E. C., Cui, J., Dennerstein, L., & Hopper, J. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6740 · Cited by 439 · cited 2×
“However, relative to menopause, this is as a function of age rather than of time (457, 462).”
BackgroundPfeilschifter, J., & Mundy, G. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2024 · Cited by 431
Self-citationBellido, T., Jilka, R. L., Boyce, B. F., Girasole, G., Broxmeyer, H., Dalrymple, S. A., Murray, R., & Manolagas, S. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117995 · Cited by 430
Yang, N. N., Venugopalan, M., Hardikar, S., & Glasebrook, A. (1996) · Science · doi:10.1126/science.273.5279.1222 · Cited by 429
Elenkov, I. J., Papanicolaou, D. A., Wilder, R. L., & Chrousos, G. P. (1996) · PubMed · Cited by 419
Monocyte Cytokine Production in an Elderly Population: Effect of Age and Inflammation
Roubenoff, R., Harris, T. B., Abad, L. W., Wilson, P. W. F., Dallal, G. E., & Dinarello, C. A. (1998) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/53a.1.m20 · Cited by 418
Activated T Lymphocytes Support Osteoclast Formation in Vitro
Horwood, N. J., Kartsogiannis, V., Quinn, J. M. W., Romas, E., Martin, T. J., & Gillespie, M. T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1623 · Cited by 416
Estrogen Modulates AT 1 Receptor Gene Expression In Vitro and In Vivo
Nickenig, G., Bäumer, A. T., Grohè, C., Kahlert, S., Strehlow, K., Rosenkranz, S., Stäblein, A., Beckers, F., Smits, J. F. M., Daemen, M. J. A. P., et al. (1998) · Circulation · doi:10.1161/01.cir.97.22.2197 · Cited by 409
Regulation of Osteoclast Function
Suda, T., Nakamura, I., Jimi, E., & Takahashi, N. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.869 · Cited by 408
Avian osteoclasts as estrogen target cells.
Oursler, M. J., Osdoby, P., Pyfferoen, J., Riggs, B. L., & Spelsberg, T. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6613 · Cited by 395
Umayahara, Y., Kawamori, R., Watada, H., Imano, E., Iwama, N., Morishima, T., Yamasaki, Y., Kajimoto, Y., & Kamada, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34025-5 · Cited by 389
Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts.
Thomson, B. M., Saklatvala, J., & Chambers, T. J. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.1.104 · Cited by 387
Oestrogen receptors – an overview
Enmark, E., & Gustafsson, J. ‐. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00545.x · Cited by 380
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 378
Burger, H. G., Dudley, E. C., Hopper, J. L., Groome, N., Guthrie, J. R., Green, A., & Dennerstein, L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6158 · Cited by 378
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.
Pacifici, R., Rifas, L., McCracken, R., Vered, I., McMurtry, C., Avioli, L. V., & Peck, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2398 · Cited by 375
The Rel/NF-κB family: friend and foe
Perkins, N. D. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01617-0 · Cited by 375
Löwik, C. W. G. M., van der Pluijm, G., Bloys, H., Hoekman, K., Bijvoet, O. L. M., Aarden, L. A., & Papapoulos, S. E. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90851-6 · Cited by 373
The Role of the Interleukin-1–Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1
Dinarello, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431011 · Cited by 373
Interleukin-6 ( IL-6 ) and the Prognosis of Abdominal Aortic Aneurysms
Jones, K. G., Brull, D. J., Brown, L. C., Sian, M., Greenhalgh, R. M., Humphries, S. E., & Powell, J. T. (2001) · Circulation · doi:10.1161/01.cir.103.18.2260 · Cited by 369
Wang, C., Fu, M., Angeletti, R. H., Siconolfi-Baez, L., Reutens, A. T., Albanese, C., Lisanti, M. P., Katzenellenbogen, B. S., Kato, S., Hopp, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100800200 · Cited by 366
ERNST, M., HEATH, J. K., & RODAN, G. A. (1989) · Endocrinology · doi:10.1210/endo-125-2-825 · Cited by 364
Yano, K., Tsuda, E., Washida, N., Kobayashi, F., Goto, M., Harada, A., Ikeda, K., Higashio, K., & Yamada, Y. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.4.518 · Cited by 363 · cited 1×
“There are preliminary reports that serum OPG levels may be associated with bone mineral density [BMD (398)], but these findings have not been confirmed by a subsequent study (235).”
ResultEffects of Interleukin-1 on Bone Turnover in Normal Mice*
BOYCE, B. F., AUFDEMORTE, T. B., GARRETT, I. R., YATES, A. J. P., & MUNDY, G. R. (1989) · Endocrinology · doi:10.1210/endo-125-3-1142 · Cited by 363
Antiinflammatory Effects of Estrogen on Microglial Activation1
Bruce-Keller, A. J., Keeling, J. L., Keller, J. N., Huang, F. F., Camondola, S., & Mattson, M. P. (2000) · Endocrinology · doi:10.1210/endo.141.10.7693 · Cited by 362
Fuller, K., Owens, J. M., Jagger, C. J., Wilson, A., Moss, R., & Chambers, T. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1733 · Cited by 362
Guerne, P. A., Carson, D. A., & Lotz, M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.499 · Cited by 361
Srivastava, S., Toraldo, G., Weitzmann, M. N., Cenci, S., Ross, F. P., & Pacifici, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010764200 · Cited by 358
Straub, R. H., Konecná, L., Hrach, S., Rothe, G., Kreutz, M. P., Schölmerich, J., Falk, W., & Lang, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.2012 · Cited by 353
Negative Interaction between the RelA(p65) Subunit of NF-κB and the Progesterone Receptor
Kalkhoven, E., Wissink, S., van der Saag, P. T., & Burg, B. V. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6217 · Cited by 352
Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice
Grainger, D. J., Kemp, P. R., Liu, A. C., Lawn, R. M., & Metcalfe, J. C. (1994) · Nature · doi:10.1038/370460a0 · Cited by 352
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
Malyankar, U. M., Scatena, M., Suchland, K. L., Yun, T. J., Clark, E. A., & Giachelli, C. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000290200 · Cited by 351
Induction of Interleukin 6 (IL-6) by Hypoxia in Vascular Cells
Yan, S. F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., Brett, J., May, L., & Stern, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11463 · Cited by 345
Krishnaswamy, G., Kelley, J., Yerra, L., Smith, J. K., & Chi, D. S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099314234 · Cited by 341
Burger, H. G. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2832 · Cited by 341
Kitazawa, R., Kimble, R. B., Vannice, J. L., Kung, V. T., & Pacifici, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117606 · Cited by 336
An, J., Tzagarakis-Foster, C., Scharschmidt, T. C., Lomri, N., & Leitman, D. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100953200 · Cited by 323
Modulation of osteoclast differentiation by local factors
Suda, T., Udagawa, N., Nakamura, I., Miyaura, C., & Takahashi, N. (1995) · Bone · doi:10.1016/8756-3282(95)00185-g · Cited by 321
Yamada, Y., Miyauchi, A., Goto, J., Takagi, Y., Okuizumi, H., Kanematsu, M., Hase, M., Takai, H., Harada, A., & Ikeda, K. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.10.1569 · Cited by 321
Aubin, J. E., & Bonnelye, E. (2000) · Osteoporosis International · doi:10.1007/s001980070028 · Cited by 319
Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene
Nicklin, M. J. H., Hughes, D. E., Barton, J. L., Ure, J. M., & Duff, G. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.303 · Cited by 317
Gilmore, W., Weiner, L. P., & Correale, J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.446 · Cited by 316
Bowie, A. G., & O’Neill, L. A. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7180 · Cited by 315
O'Brien, C. A., Gubrij, I., Lin, S.-C., Saylors, R. L., & Manolagas, S. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19301 · Cited by 313
Hofbauer, L. C., Dunstan, C. R., Spelsberg, T. C., Riggs, B. L., & Khosla, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9394 · Cited by 311
Ammann, P., Rizzoli, R., Bonjour, J. P., Bourrin, S., Meyer, J. M., Vassalli, P., & Garcia, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119333 · Cited by 310
Sheppard, K.-A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G., Gerritsen, M. E., & Collins, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29291 · Cited by 305
Both Erk and p38 Kinases Are Necessary for Cytokine Gene Transcription
Carter, A. B., Monick, M. M., & Hunninghake, G. W. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.4.3420 · Cited by 305
Takai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K., & Yamada, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27091 · Cited by 299
The Molecular Pharmacology of SERMs
McDonnell, D. P. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00177-0 · Cited by 299
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
Chenu, C., Pfeilschifter, J., Mundy, G. R., & Roodman, G. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5683 · Cited by 295
Self-citationGrimaldi, C. M., Michael, D. J., & Diamond, B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1886 · Cited by 290
Expression of Estrogen Receptor β in Rat Bone
Onoe, Y., Miyaura, C., Ohta, H., Nozawa, S., & Suda, T. (1997) · Endocrinology · doi:10.1210/endo.138.10.5575 · Cited by 290
Jakacka, M., Ito, M., Weiss, J., Chien, P.-Y., Gehm, B. D., & Jameson, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008384200 · Cited by 284
Estradiol Down‐Regulates LPS‐Induced Cytokine Production and NFkB Activation in Murine Macrophages
Deshpande, R., Khalili, H., Pergolizzi, R. G., Michael, S. D., & Chang, M. Y. (1997) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1997.tb00275.x · Cited by 284
Plasma Membrane Estrogen Receptors Are Coupled to Endothelial Nitric-oxide Synthase through Gαi
Wyckoff, M. H., Chambliss, K. L., Mineo, C., Yuhanna, I. S., Mendelsohn, M. E., Mumby, S. M., & Shaul, P. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100312200 · Cited by 282
The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases
Prud'homme, G. J., & Piccirillo, C. A. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0339 · Cited by 276
Pottratz, S. T., Bellido, T., Mocharla, H., Crabb, D., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117100 · Cited by 274
Progesterone as a Bone-Trophic Hormone
PRIOR, J. C. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-386 · Cited by 273
Kimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., & Pacifici, R. (1995) · Endocrinology · doi:10.1210/endo.136.7.7789332 · Cited by 273
Kimble, R. B., Srivastava, S., Ross, F. P., Matayoshi, A., & Pacifici, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28890 · Cited by 272
Perspectives: Interleukin-6: An osteotropic factor?
Roodman, G. D. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070502 · Cited by 272
Rubanyi, G. M., Freay, A. D., Kauser, K., Sukovich, D., Burton, G., Lubahn, D. B., Couse, J. F., Curtis, S. W., & Korach, K. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119426 · Cited by 270
OURSLER, M. J., CORTESE, C., KEETING, P., ANDERSON, M. A., BONDE, S. K., RIGGS, B. L., & SPELSBERG, T. C. (1991) · Endocrinology · doi:10.1210/endo-129-6-3313 · Cited by 265
Rosselli, M., Imthurn, B., Keller, P. J., Jackson, E. K., & Dubey, R. K. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.848 · Cited by 265
Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions
Seino, Y., Ikeda, U., Ikeda, M., Yamamoto, K., Misawa, Y., Hasegawa, T., Kano, S., & Shimada, K. (1994) · Cytokine · doi:10.1016/1043-4666(94)90013-2 · Cited by 263
Browner, W. S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.631 · Cited by 260
Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures.
Pfeilschifter, J., Seyedin, S. M., & Mundy, G. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113647 · Cited by 258
Self-citationInterleukin-1β is a potent inhibitor of bone formation in vitro
Dr. Stashenko, P., Dewhirst, F. E., Rooney, M. L., Desjardins, L. A., & Heeley, J. D. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020612 · Cited by 255
Cytokines, bone remodeling, and estrogen deficiency: a 1998 update
JILKA, R. (1998) · Bone · doi:10.1016/s8756-3282(98)00077-5 · Cited by 255
Scheidt-Nave, C. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2032 · Cited by 255
Srivastava, S., Weitzmann, M. N., Cenci, S., Ross, F. P., Adler, S., & Pacifici, R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7094 · Cited by 255
Ito, A., Bebo, B. F., Matejuk, A., Zamora, A., Silverman, M., Fyfe-Johnson, A., & Offner, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.542 · Cited by 254
Steroid and gonadotropin levels in women during the peri-menopausal years
Longcope, C., Franz, C., Morello, C., Baker, R., & Johnston, C. C. (1986) · Maturitas · doi:10.1016/0378-5122(86)90025-3 · Cited by 253
The Actions and Interactions of Sex Steroids and Growth Factors/Cytokines on the Skeleton
Spelsberg, T. C. (1999) · Molecular Endocrinology · doi:10.1210/me.13.6.819 · Cited by 251
Lymphocytes are important in early atherosclerosis
Song, L., Leung, C. C., & Schindler, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11380 · Cited by 249
Androgens Alter the Cytokine Profile and Reduce Encephalitogenicity of Myelin-Reactive T Cells
Bebo, B. F., Schuster, J. C., Vandenbark, A. A., & Offner, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.35 · Cited by 243
The role of p38 mitogen-activated protein kinase in IL-1 beta transcription.
Baldassare, J. J., Bi, Y., & Bellone, C. J. (1999) · PubMed · Cited by 242
The Functional Block of TNF but Not of IL-6 Prevents Bone Loss in Ovariectomized Mice
Kimble, R. B., Bain, S., & Pacifici, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.935 · Cited by 241 · cited 1×
“The essential role of TNF- in ovariectomyassociated bone loss is suggested by the finding that treatment of ovariectomized mice with TNF- binding protein, a potent inhibitor of TNF- , completely prevented bone loss (11, 369).”
BackgroundRole of Transforming Growth Factor- in Tissue Injury and Repair
Grande, J. P. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-214-44066 · Cited by 241
Elias, J. A., & Lentz, V (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.1.161 · Cited by 239
Diodato, M. D., Knöferl, M. W., Schwacha, M. G., Bland, K. I., & Chaudry, I. H. (2001) · Cytokine · doi:10.1006/cyto.2001.0861 · Cited by 239
Cytokine control in human endometrium
Kelly, R. W., King, A. E., & Critchley, H. O. (2001) · Reproduction · doi:10.1530/rep.0.1210003 · Cited by 239
Tsukii, K., Shima, N., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Yano, K., Shibata, O., Udagawa, N., Yasuda, H., Suda, T., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8610 · Cited by 238
Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro
Akatsu, T., Takahashi, N., Udagawa, N., Imamura, K., Yamaguchi, A., Sato, K., Nagata, N., & Dr. Suda, T. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060212 · Cited by 235
Research works printed but not linked: 31
- Vargas, 1996, Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy., J Bone Miner Res, 11, 1926, 10.1002/jbmr.5650111214 · doi:10.1002/jbmr.5650111214
- Girasole, 1995, Increased serum-soluble interleukin-6 receptor levels are induced by ovariectomy, prevented by estrogen replacement and reversed by alendronate administration, J Bone Miner Res, 10, A86
- Martinetti, 2000, The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers., J Steroid Biochem Mol Biol, 75, 65, 10.1016/S0960-0760(00)00138-2 · DOI
- O’Brien, 1999, In vivo demonstration of the negative transcriptional control of the IL-6 gene by estrogen using IL-6 promoter-luciferase transgenic mice, J Bone Miner Res, 14, S179
- Wang, 1999, The expression of transforming growth factor-β and interleukin-1β mRNA and the response to 1,25(OH)2D3′ 17β-estradiol, and testosterone is age-dependent in primary cultures of mouse-derived osteoblasts in vitro., Endocrine, 11, 13, 10.1385/ENDO:11:1:13 · doi:10.1385/endo:11:1:13
- Scheidt-Nave, 1999, Serum interleukin-6 is a major predictor of bone loss in women specific to the first decade past menopause, J Bone Miner Res, 14, S147
- Sunyer, 1997, Estrogen decreases the steady state levels of the IL-1 signaling receptor (type I) while increasing those of the IL-1 decoy receptor (type II) in human osteoclast-like cells, J Bone Miner Res, 12, 131
- Woodfork, 2001, Cytokine and nitric oxide release by J774A.1 macrophages is not regulated by estradiol., Life Sci, 69, 2287, 10.1016/S0024-3205(01)01304-2 · doi:10.1016/s0024-3205(01)01304-2
- Paul, 1998, Effects of raloxifene and hormone replacement therapy on homocysteine and c-reactive protein levels in postmenopausal women, Circulation, 17, I7
- Sachs, 1994, The network of hematopoietic cytokines., Proc Soc Exp Biol Med, 206, 170, 10.3181/00379727-206-43736 · doi:10.3181/00379727-206-43736
- Simoncini, 2000, Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase., J Clin Endocrinol Metab, 85, 2966, 10.1210/jcem.85.8.6853 · doi:10.1210/jcem.85.8.6853
- Konukoglu, 2000, Effects of hormone replacement therapy on plasma nitric oxide and total thiol levels in postmenopausal women., J Toxicol Environ Health, 60, 81, 10.1080/009841000156501 · doi:10.1080/009841000156501
- Jouzeau, 1999, Modulation of IL-1 effects on cartilage by NO synthase inhibitors: pharmacological studies in rats., Osteoarthritis Cartilage, 7, 382, 10.1053/joca.1998.0218 · doi:10.1053/joca.1998.0218
- Subbiah, 1998, Mechanisms of cardioprotection by estrogens., Proc Soc Exp Biol Med, 217, 23, 10.3181/00379727-217-44201 · doi:10.3181/00379727-217-44201
- Melton, 2000, Sex is all in the brain: report of a Novartis Foundation Symposium on the neuronal and cognitive effects of oestrogens, London UK, 7–9 September 1999., Trends Endocrinol Metab, 11, 69, 10.1016/S1043-2760(99)00231-3 · DOI
- Gurdol, 1997, Changes in enzymatic antioxidant defense system in blood and endometrial tissues of women after menopause., Res Comm Mol Pathol Pharmacol, 97, 38
- Seo, 1995, Immature B-lymphopoiesis accumulating in estrogen deficiency stimulate IL-6 production by mouse bone marrow stromal cells, J Bone Miner Res, 10, S159
- Akgul, 1998, Hormone replacement therapy and urinary prostaglandins in postmenopausal women., Maturitas, 30, 79, 10.1016/S0378-5122(98)00046-2 · doi:10.1016/s0378-5122(98)00046-2
- Pacifici, 1995, Cytokines and osteoclast activity, Calcif Tissue Int, 56, S27, 10.1007/BF03354648 · doi:10.1007/bf03354648
- Marusic, 1991, Effects of transforming growth factor-β and IL-1 α on prostaglandin synthesis in serum-deprived osteoblastic cells., J Immunol, 146, 2633, 10.4049/jimmunol.146.8.2633 · doi:10.4049/jimmunol.146.8.2633
- Harrison, 1990, Interleukin-1 α and phorbol ester inhibit collagen synthesis in osteoblastic MC3T3-E1 cells by a transcriptional mechanism., Mol Endocrinol, 4, 184, 10.1210/mend-4-2-184 · doi:10.1210/mend-4-2-184
- Bradbeer, 1996, An orally active inhibitor of cytokine synthesis prevents bone loss in the ovariectomized rat, J Bone Miner Res, 11, 123
- Slater, 1994, Modulation of growth factor incorporation into ECM of human osteoblast-like cells in vitro by 17 β estradiol, Am J Physiol, 267, E990
- Erdmann, 1998, Effects of estrogen on the concentration of insulin-like growth factor-I in rat bone matrix., Bone, 22, 503, 10.1016/S8756-3282(98)00043-X · doi:10.1016/s8756-3282(98)00043-x
- Elhage, 2000, Loss of atheroprotective effect of estradiol in immunodeficient mice., Endocrinology, 141, 462, 10.1210/endo.141.1.7377 · doi:10.1210/endo.141.1.7377
- Masiukiewicz, 2000, Estrogen modulates parathyroid hormone-induced interleukin-6 production in vivo and in vitro., Endocrinology, 141, 2526, 10.1210/endo.141.7.7537 · doi:10.1210/endo.141.7.7537
- Tsukamoto, 1999, Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women., J Hum Genet, 44, 148, 10.1007/s100380050132 · DOI
- Langdahl, 1999, An 86 basepair repeat in the interleukin 1 receptor antagonist gene is weakly associated with peak bone mass, but not with early postmenopausal bone loss or the response to HRT, J Bone Miner Res, 14, S334
- Ferrari, 2001, A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women., Arthritis Rheum, 44, 196, 10.1002/1529-0131(200101)44:1<196::AID-ANR26>3.0.CO;2-5 · doi:10.1002/1529-0131(200101)44:1<196::aid-anr26>3.0.co;2-5
- Kluft, 1999, Statins and C-reactive protein., Lancet, 353, 1274, 10.1016/S0140-6736(05)66951-6 · doi:10.1016/s0140-6736(05)66951-6
- Mbalaviele, 1999, Blockade of cytokine-mediated human osteoclastogenesis by activation of peroxisome proliferator-activated receptor-γ pathway, J Bone Miner Res, 14, S358
Cited by
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)
Berenbaum, F. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.11.012 · Cited by 1,718
The Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449
“Several studies have shown higher IL-6 levels in postmenopausal compared with premenopausal women (79).”
BackgroundThe role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
Sambrook, P., & Cooper, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68891-0 · Cited by 1,165
Metadata
- Authors
- Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2002-02-01
- Volume
- 23
- Issue
- 1
- Pages
- 90-119
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2060551064
- Cited by
- 914
- References
- 487
- FWCI
- 16.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.